|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||9.00 - 9.40|
|52 Week Range||0.81 - 40.63|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.59|
The next five days will still be full of news surrounding the cannabis space. We have compiled a list of main things that cannabis investors should be keeping an eye on this week. Ontario Lottery And New ...
The US cannabis market, in general, has been opening up, especially since Canada legalized marijuana in late 2018. Despite the progress being slow, 11 states already allow the recreational use of marijuana. Medical marijuana is legal in 33 states.
“We are pleased to further expand access to Cresco Labs shares with our listing on the Frankfurt Stock Exchange,” said Cresco Labs CEO & Co-Founder Charlie Bachtell. The Frankfurt Stock Exchange is the largest exchange in Germany and one of the largest markets for trading equity securities in the world.
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today provided comments on the signing into law of legislation that makes Illinois’ medical-use cannabis program permanent, expands the list of qualifying medical conditions, and allows for nurse practitioners and physician’s assistants to certify a patient’s eligibility for the program in addition to doctors. The new law signed by Illinois Governor JB Pritzker on August 12, 2019 takes effect immediately and adds debilitating illnesses such as chronic pain, migraines and irritable bowl syndrome to the list of qualifying medical conditions. Cresco Labs CEO & Co-Founder Charlie Bachtell commented, “We have seen incredible growth in the Illinois medical cannabis program in 2019 with the number of registered patients increasing by more than 50% since the start of the year.
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has received regulatory approval for its acquisition of 100% of the membership interests of Gloucester Street Capital, LLC (“Gloucester”), the parent entity of Valley Agriceuticals, LLC ("Valley Ag") via a merger between Gloucester and an indirect subsidiary of Cresco Labs. Valley Ag holds one of the 10 vertically integrated cannabis business licenses granted in the State of New York by the New York State Department of Health.
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, will report its financial results for the second quarter ended June 30, 2019 on Wednesday, August 21, 2019 after the market closes. The Company will hold a conference call and webcast to discuss its business and financial results on Wednesday, August 21, 2019 at 5 p.m. Eastern Time (4 p.m. Central Time). The conference call may be accessed via Cresco Labs’ investor relations website at investors.crescolabs.com or by dialing 866-688-4235 (409-216-0711 for international callers) and providing conference ID 3385937.
Cresco Labs, Inc. (CL.CN) (CRLBF) (“Cresco” or “the Company”) one of the largest vertically integrated multistate cannabis operators in the United States, today announced that Charlie Bachtell, CEO & Co-Founder, and Joe Caltabiano, President & Co-Founder, will participate in the Canaccord Genuity 39th Annual Growth Conference on Wednesday, August 7, 2019 in Boston. The Company’s presentation is scheduled for 9:30 a.m. ET / 6:30 a.m. PT. Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy.
Cresco Labs Inc. (CSE: CL) (OTC: CRLBF) announced Monday the launch of its new dispensary brand Sunnyside. Sunnyside is a wellness-base retailer that provides a holistic experience. What makes Sunnyside special, according to the company, is its focus on cannabis education and a large portfolio of cannabis brands.
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today unveiled Sunnyside*, a new dispensary brand created to accelerate industry growth and shift people’s expectations and perceptions around shopping for cannabis from intimidation and doubt to curiosity and acceptance through a new retail and marketing approach. Sunnyside* is more than a dispensary—it’s a wellness-based retailer offering a holistic experience for anyone who considers, or would consider, cannabis to be an integral part of their personal wellness program. A more sophisticated and familiar shopping destination that combines high-end design from healthcare, retail and hospitality, Sunnyside* elevates the value dispensaries can add to a community with a bright, welcoming aesthetic and convenient shopping whether in-store or online.
Cresco Labs, Inc. (CL.CN) (CRLBF) (“Cresco” or “the Company”) one of the largest vertically integrated multistate cannabis operators in the United States, announced it has obtained eligibility with The Depository Trust Company (DTC) for its common shares listed on the OTCQX. “Our shareholders will now be able to electronically transfer shares between brokerages in the U.S.,” said Charles Bachtell, Co-founder and CEO of Cresco Labs. A subsidiary of Depository Trust and Clearing Corp, DTC was established in 1973 to reduce costs and provide clearing and settlement efficiencies.
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that Angie Demchenko has joined the Company as its first Chief People Officer. Ms. Demchenko most recently served as Vice President, Head of Human Resources for Starwood Retail Partners, a leading operator of shopping malls and lifestyle centers.
Life science company executives will share vision and answer audience questions at VirtualInvestorConferences.com NEW YORK , July 9, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the ...
The whole benefit of investing in the U.S. multi-state operators (MSOs) is playing out as planned with the approval of adult-use cannabis in Illinois. The large market opportunity immediately adds value to the Cresco Labs (CRLBF) business without the company having to acquire another business or look towards global expansion. The stock should not be trading at $10.50 with their growing total addressable market.Already Focused On Illinois The state of Illinois approved adult-use cannabis effective January 1, 2020. The state already had medical marijuana where Cresco Labs had 5 dispensaries addressing the need of the large population in Illinois that includes Chicago.(Source: Cresco Labs presentation)The company is in the middle of working on closing the Origin House (ORHOF) merger that provides wholesale access to 500 dispensaries in California. The opportunity in Illinois is estimated at a potential $2 to $4 billion market size leaving Cresco Labs in a great position whether or not the company gets approval to close that merger.As part of the Illinois approval, Cresco Labs can open 5 more dispensaries to reach a total of 10. The company plans to have these locations open before the adult-use market opens up on January 1 along with expanded cultivation facilities to reach the max allowed by the state.Illinois is well positioned to match the future importance of states like California and Florida as Cresco Labs completes acquisitions already in the works.Still Waiting Cresco Labs is still waiting on several transformational mergers to close. The Origin House deal got the typical request from regulators for additional information. Even the VidaCann merger in Florida hasn’t closed, but the company has now opened additional dispensaries along with plans to reach 20 locations by the end of 2019.The company has pending transactions that will allow Cresco Labs to enter New York, Massachusetts and Florida along with licenses to expand into Michigan. The deals gave the company access to 51 dispensaries and the approval in Illinois brings the total to 56.In addition, the revenue forecasts at the time of the merger topped $1 billion by 2021 and the new expansion in a large market should provide a nice boost to those original estimates. Cresco Labs should be positioned for substantial growth over the next couple of years.Once the mergers with Origin House and VidaCann close, the company will have substantial positions in the key cannabis markets of California, Florida and Illinois that all offer market opportunities that might exceed the current struggling Canadian market.At the time of the merger, the company had listed the fully diluted valuation in the C$5.5 billion range. With about a 15% decline in the stock price since, the updated valuation is about C$4.8 billion. The converted value is about $3.7 billion providing a very reasonable value for all of the opportunities for MSOs building scale in the U.S.TakeawayThe key investor takeaway is that Cresco Labs remains an emerging MSO giant. The cannabis company has substantial growth plans right under the surface of investor view due to the pending acquisitions.Within a year, the company will go from reporting quarterly revenues in the $20 million range to topping $125 million. The stock will rise accordingly.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here.Read more on Cresco Labs * Stay Away from Cresco Labs Stock Until the Smoke Clears * Cresco Labs (CRLBF) Worth Another Look Following Earnings More recent articles from Smarter Analyst: * Analysts Go Gaga Over Nvidia (NVDA) Stock * Why You Should Keep Tesla (TSLA) and W.W. Grainger (GWW) Stocks on Your Sell List * David Shaw Makes Waves in the Semiconductor World: Advanced Micro Devices (AMD), Micron (MU) * Billionaire Izzy Englander Cuts Loose in Amazon (AMZN) and Nio, Inc. (NIO) Stocks
Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that Mo Dastagir has joined the Company as its new Chief Information Officer. Mr. Dastagir succeeds Zach Marburger, who is taking on a new role at Cresco as Entrepreneur in Residence.
If you have doubts that cannabis is on its way from illegal to industrial, take a look inside Cresco Labs’ custom built, 43-thousand square-foot production facility in Joliet, Illinois.